ASCO 2019: Women Don't Need Reminders to Take Aromatase Inhibitors, They Need Better Treatments for Side Effects
A member of the Breastcancer.org Professional Advisory Board, Dr. Dawn Hershman leads the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at Columbia University, where she is professor of medicine and epidemiology. Dr. Hershman is a nationally recognized expert in breast cancer treatment, prevention, and survivorship. '
At this ASCO annual meeting, Dr. Hershman presented results from a study looking at whether text messaging could increase the number of women who stick to their aromatase inhibitor treatment plans.
Listen to the podcast to hear Dr. Hershman talk about:
Create your
podcast in
minutes
It is Free